HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI)
K-Number: K221704 · 2022-11-22
Device Summary
Frequently Asked Questions
What is the HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI)?
HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI) is a medical device that received FDA 510(k) clearance on 2022-11-22. It is manufactured by Edwards Lifesciences, LLC. The 510(k) number is K221704.
When was HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI) approved by the FDA?
HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI) received FDA 510(k) clearance on 2022-11-22, under approval number K221704.
What company makes HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI)?
HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI) is manufactured by Edwards Lifesciences, LLC.
What is the FDA product code for HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI)?
The FDA product code for HemoSphere Advanced Monitor, Right Ventricular Pressure (RVP), Global Hypoperfusion Index (GHI) is DQK.
Related Clinical Trials
Related PubMed Literature
Other Devices by Edwards Lifesciences, LLC
Related Devices (Code: DQK)
Official Source
View on FDA Database →Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.